GlobalData on MSN6d
MHRA approves trofolastat for prostate cancer diagnostic imaging
Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...
News Medical on MSN3d
World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Mirage News6d
MHRA Greenlights Trofolastat for Prostate Cancer Imaging
As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...
pharmaphorum2d
UK first to approve Rotop's prostate cancer imaging agent
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...
Open Access Government2d
MHRA approves trofolastat for prostate cancer imaging
The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...